12 research outputs found
Global research priorities related to the World Health Organization Labour Care Guide: results of a global consultation
Background The World Health Organization (WHO) published the WHO Labour Care Guide (LCG) in 2020 to support
the implementation of its 2018 recommendations on intrapartum care. The WHO LCG promotes evidence-based
labour monitoring and stimulates shared decision-making between maternity care providers and labouring women.
There is a need to identify critical questions that will contribute to defining the research agenda relating to implementation
of the WHO LCG.
Methods This mixed-methods prioritization exercise, adapted from the Child Health and Nutrition Research Initiative
(CHNRI) and James Lind Alliance (JLA) methods, combined a metrics-based design with a qualitative, consensusbuilding
consultation in three phases. The exercise followed the reporting guideline for priority setting of health
research (REPRISE). First, 30 stakeholders were invited to submit online ideas or questions (generation of research
ideas). Then, 220 stakeholders were invited to score "research avenues" (i.e., broad research ideas that could be
answered through a set of research questions) against six independent and equally weighted criteria (scoring of
research avenues). Finally, a technical working group (TWG) of 20 purposively selected stakeholders reviewed the
scoring, and refined and ranked the research avenues (consensus-building meeting).
Results Initially, 24 stakeholders submitted 89 research ideas or questions. A list of 10 consolidated research avenues
was scored by 75/220 stakeholders. During the virtual consensus-building meeting, research avenues were refined,
and the top three priorities agreed upon were: (1) optimize implementation strategies of WHO LCG, (2) improve
understanding of the effect of WHO LCG on maternal and perinatal outcomes, and the process and experience of
labour and childbirth care, and (3) assess the effect of the WHO LCG in special situations or settings. Research avenues
related to the organization of care and resource utilization ranked lowest during both the scoring and consensusbuilding
process.
Conclusion This systematic and transparent process should encourage researchers, program implementers, and
funders to support research aligned with the identified priorities related to WHO LCG. An international collaborative
platform is recommended to implement prioritized research by using harmonized research tools, establishing a
repository of research priorities studies, and scaling-up successful research results
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase
Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model
The hepatitis C virus (HCV) chronically infects 2% of the world population and effective treatment is limited by long duration and significant side-effects. Here, we describe a novel drug, intended as a “single-shot ” therapy, which expresses three short hairpin RNAs (shRNAs) that simultaneously target multiple conserved regions of the HCV genome as confirmed in vitro by knockdown of an HCV replicon system. Using a recombinant adeno-associated virus (AAV) serotype 8 vector for delivery, comprehensive transduction of hepatocytes was achieved in vivo in a nonhuman primate (NHP) model following a single intravenous injection. However, dose ranging studies performed in 13 NHP resulted in high-expression levels of shRNA from wild-type (wt) Pol III promoters and dose-dependent hepatocellular toxicity, the first demonstration of shRNA-related toxicity in primates, establishing that the hepatotoxicity arises from highly conserved features of the RNA interference (RNAi) pathway. In the second generation drug, each promoter was re-engineered to reduce shRNA transcription to levels that circumvent toxicity but still inhibit replicon activity. In vivo testing of this modified construct in 18 NHPs showed conservation of hepatocyte transduction but complete elimination of hepatotoxicity, even with sustained shRNA expression for 50 days. These data support progression to a clinical study for treatment of HCV infection
Considering ergonomics in the accident and emergency department: possible or not
Accident and Emergency Department is one of the medical treatment departments that deal with emergency medicine, where patients come without making any appointment in advance. In Malaysia, it was known as Casualty Department previously. The nature of Accident and Emergency Department is complex due to the unpredictability of this department, Accident and Emergency Department is a workplace for multiple types of individuals. This study looked into the numbers of studies that has been carried out in area of ergonomics at Emergency Department of Malaysia Hospitals compared to other department. Numbers of studies are compared to see the loop that exists in Accident and Emergency Department when it comes to ergonomics. This paper will see the ergonomics issues face by healthcare personnel compares to other department in hospitals. Findings showed that, Accident and Emergency Department of Malaysia Hospitals has not been given enough attention regarding the implementation or ergonomics